11/17/2026 | News release | Distributed by Public on 11/17/2026 08:02
On 16 November 2026, the information event Regulatory & Beyond took place at the Kursaal Bern. The event was a great success, bringing together more than 450 professionals from industry, regulatory authorities, and other regulatory fields.
Participants gained valuable insights into medicinal product authorisation as well as key regulatory developments and current challenges. Expert presentations, a breakout session on the authorisation of veterinary medicinal products and various networking opportunities fostered professional dialogue and the exchange of experiences and perspectives.
We would like to thank all speakers, participants and contributors for their strong commitment and valuable contributions, which helped make the event a success.
Medicinal Product Authorisation and Vigilance: We are consolidating all medicinal product groups and harnessing synergies(PDF, 2 MB, 16.11.2026)Eveline Trachsel
Comparison of indication wording between Swissmedic, EMA and the FDA(PDF, 970 kB, 16.11.2026)Matea Zosso, Tanja Colin
Innovations in reporting tools (ElViS 2.0) and risk communication(PDF, 2 MB, 16.11.2026)Stephanie Storre, Thomas Stammschulte
Cooperation instead of isolation - Life Cycle Management in international regulatory networks(PDF, 1 MB, 16.11.2026)Ulla Grauschopf
Evergreens im Regulatory Assessment Tierarzneimittel: Die Do's & Don'ts, die zählen(PDF, 259 kB, 16.11.2026)Alexandre Scherer
Facts